Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Ryan Crowe

Tracked across 1 events · 7 articles · First seen May 18, 2026 · Last active Jul 30, 2026

Sentiment
-40
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -40
Regulatory
Impact: Ryan Crowe, Senior Vice President of Investor Relations at Regeneron Pharmaceuticals, made optimistic statements about the fianlimab + Libtayo trial that are now under investigation for potentially misleading investors.
May 18, 2026 · 7 articles
70 Ryan Crowe made allegedly misleading statementsRegeneron Securities Class...
ERGEN INTELLIGENCE
Track Ryan Crowe live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.